ONYVAX
Onyvax is developing new cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells. Onyvax's products specifically target cancer cells, increasing the likelihood that they will be effective while minimising side effects associated with many conventional treatments. These therapies can broadly be classed as therapeutic cancer vaccines.
ONYVAX
Industry:
Biotechnology Health Care Therapeutics
Founded:
1997-01-01
Address:
Bradford, Somerset, United Kingdom
Country:
United Kingdom
Website Url:
http://www.onyvax.com
Total Employee:
11+
Status:
Closed
Contact:
44 20 8682 9494
Total Funding:
29.81 M USD
Technology used in webpage:
SPF Amazon Amazon Ohio Region NameBright
Investors List
SR One
SR One investment in Series C - Onyvax
3i Group
3i Group investment in Series C - Onyvax
Alice Ventures
Alice Ventures investment in Series C - Onyvax
Excalibur Fund Managers
Excalibur Fund Managers investment in Series C - Onyvax
Alta Berkeley Venture Partners
Alta Berkeley Venture Partners investment in Series C - Onyvax
3i Group
3i Group investment in Venture Round - Onyvax
Alta Berkeley Venture Partners
Alta Berkeley Venture Partners investment in Venture Round - Onyvax
SR One
SR One investment in Venture Round - Onyvax
Alice Ventures
Alice Ventures investment in Venture Round - Onyvax
Excalibur Fund Managers
Excalibur Fund Managers investment in Venture Round - Onyvax
Official Site Inspections
http://www.onyvax.com
- Host name: 104.21.15.43
- IP address: 104.21.15.43
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
